CASTALDO, ALICE
 Distribuzione geografica
Continente #
EU - Europa 336
NA - Nord America 213
AS - Asia 127
SA - Sud America 19
AF - Africa 13
Totale 708
Nazione #
US - Stati Uniti d'America 210
RU - Federazione Russa 158
IT - Italia 106
SG - Singapore 64
HK - Hong Kong 34
NL - Olanda 28
DE - Germania 20
CN - Cina 18
BR - Brasile 15
CI - Costa d'Avorio 9
FI - Finlandia 9
GB - Regno Unito 5
VN - Vietnam 4
KR - Corea 3
ZA - Sudafrica 3
AT - Austria 2
CA - Canada 2
CO - Colombia 2
ES - Italia 2
IL - Israele 2
UA - Ucraina 2
EC - Ecuador 1
FR - Francia 1
IE - Irlanda 1
IN - India 1
IQ - Iraq 1
KE - Kenya 1
LT - Lituania 1
MX - Messico 1
PL - Polonia 1
VE - Venezuela 1
Totale 708
Città #
Moscow 41
Naples 38
Singapore 38
Hong Kong 34
Ashburn 29
Chandler 27
Santa Clara 25
Amsterdam 24
Napoli 21
Helsinki 7
Lawrence 7
Los Angeles 6
Hefei 5
Millbury 5
Rome 5
Des Moines 4
Dong Ket 4
Frankfurt am Main 4
Villaricca 4
Boston 3
Fairfield 3
Limatola 3
London 3
Nola 3
Seoul 3
Washington 3
Barcelona 2
Berlin 2
Foggia 2
Gargazon 2
Lappeenranta 2
Munich 2
Nuremberg 2
San Severo 2
Shanghai 2
The Dalles 2
Vienna 2
Baghdad 1
Bento Gonçalves 1
Boardman 1
Boituva 1
Brusque 1
Carlos Barbosa 1
Cartagena 1
Chiusano di San Domenico 1
Chongqing 1
Cotia 1
Dracena 1
Dublin 1
Düsseldorf 1
Falkenstein 1
Formia 1
Guimarães 1
Houston 1
Jerusalem 1
Jinan 1
Kochi 1
Kronberg 1
Laojunmiao 1
Lu'an 1
Maracaibo 1
Mexico City 1
Montenegro 1
Mugnano di Napoli 1
Nairobi 1
Oban 1
Ottawa 1
Padre Bernardo 1
Palermo 1
Quito 1
Rio Bonito 1
Rio de Janeiro 1
Santo André 1
Seattle 1
São Gabriel 1
São Gabriel do Oeste 1
Tel Aviv 1
Tianjin 1
Torun 1
Turin 1
Wilmington 1
Woodbridge 1
Wuxi 1
Totale 417
Nome #
A complicated association between two different genetic rare disorders: Cystic Fibrosis and Spinal Muscular Atrophy 84
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 68
Salivary cytokines and airways disease severity in patients with cystic fibrosis 65
Oxylipin profile in saliva from patients with cystic fibrosis reveals a balance between pro-resolving and pro-inflammatory molecules 63
Immunophenotyping of peripheral blood cells allows to discriminate MIS-C and Kawasaki disease 58
Impaired cholesterol metabolism in the mouse model of cystic fibrosis. A preliminary study 58
MIS-C: A COVID-19-associated condition between hypoimmunity and hyperimmunity 57
A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres. 54
Lipidomic alterations in human saliva from cystic fibrosis patients 53
Impaired Ratio of Unsaturated to Saturated Non-Esterified Fatty Acids in Saliva from Patients with Cystic Fibrosis 53
One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes 34
Liver biochemical indexes and cholesterol metabolism in cystic fibrosis patients with F508del/CFTR variant genotype after elexacaftor/tezacaftor/ivacaftor treatment 30
TAS2R38 genotype and CRS severity in children with cystic fibrosis 24
Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype 24
Metabolomic profiling of saliva from cystic fibrosis patients 22
Totale 747
Categoria #
all - tutte 3.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.015


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 6 1
2020/202128 4 0 7 4 0 0 0 3 1 4 0 5
2021/202250 0 0 3 0 0 8 1 0 3 7 16 12
2022/2023113 7 6 3 1 13 6 14 6 22 24 9 2
2023/2024119 4 10 17 9 2 21 6 19 0 7 14 10
2024/2025427 26 19 0 15 14 46 38 50 23 42 154 0
Totale 747